Health behaviour of adults with congenital heart defects (EmaH) as a basis for establishing primary preventive medical measures to reduce health risks

Health behaviour of adults with congenital heart defects (EmaH) as a basis for establishing primary preventive medical measures to reduce health risks - MERLIN-AHF - Medizinische Erfolge langfristig bewahren durch integrierte Versorgung angeborener Herzfehler

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00017701

Enrollment

3000

Registered

2019-08-01

Start date

2019-06-17

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Q20 Q21 Q22 Q23 Q24 Q25 Q26

Interventions

Group 1: Adults with congenital heart defects are asked about their health behaviour as part of a questionnaire survey.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: The study will include adults (18 years of age and older) with a congenital heart defect (ACHD), regardless of whether the defect is native or has been surgically and/or interventionally treated.

Exclusion criteria

Exclusion criteria: Refusal by the patient to participate in the study, patients with cognitive impairments, or patients with any language barriers that prevent them from understanding the study, or non-existence of the informed consent form.

Design outcomes

Primary

Measure	Time frame
The aim of the study is to record the actual state of health of ACHD and the change in the state of health under routine treatment over a period of 12 months. In detail is planned: - Recording of modifiable cardiovascular risk factors (e.g. lifestyle factors, anthropometric parameters) as well as early stages of coexistent cardiovascular diseases and their change during routine treatment over a period of 12 months. - Comparison of the risk factor constellation between individual CHD groups, as well as clarification of the relationship with the type and timing of previous interventions on the heart or large vessels, and epidemiological data (e.g. age, sex, accompanying syndromes, etc.). - Comparison of the risk factor constellation within the study population and its fluctuation over a period of 12 months under routine treatment (with regard to: dietary behaviour, exercise behaviour, non-cardiac co-morbidities, health-related quality of life, disease identity, anxiety and depression, social status, information on the disease-related significance of diet, exercise, health, nicotine, alcohol, drug use, sleep, stress)	—

Measure

Time frame

The aim of the study is to record the actual state of health of ACHD and the change in the state of health under routine treatment over a period of 12 months. In detail is planned: - Recording of modifiable cardiovascular risk factors (e.g. lifestyle factors, anthropometric parameters) as well as early stages of coexistent cardiovascular diseases and their change during routine treatment over a period of 12 months. - Comparison of the risk factor constellation between individual CHD groups, as well as clarification of the relationship with the type and timing of previous interventions on the heart or large vessels, and epidemiological data (e.g. age, sex, accompanying syndromes, etc.). - Comparison of the risk factor constellation within the study population and its fluctuation over a period of 12 months under routine treatment (with regard to: dietary behaviour, exercise behaviour, non-cardiac co-morbidities, health-related quality of life, disease identity, anxiety and depression, social status, information on the disease-related significance of diet, exercise, health, nicotine, alcohol, drug use, sleep, stress)

—

Countries

Germany

Contacts

Public ContactHarald Kaemmerer

Klinik für angeborene Herzfehler und KinderkardiologieDeutsches Herzzentrum München

kaemmerer@dhm.mhn.de00498912183025

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026